- Home
- OGEN vs IPDN Comparison
OGEN vs IPDN Comparison
Compare OGEN & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- IPDN
- Stock Information
- Founded
- OGEN 1996
- IPDN 2003
- Country
- OGEN United States
- IPDN United States
- Employees
- OGEN N/A
- IPDN N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- IPDN EDP Services
- Sector
- OGEN Health Care
- IPDN Technology
- Exchange
- OGEN Nasdaq
- IPDN Nasdaq
- Market Cap
- OGEN 1.2M
- IPDN 5.2M
- IPO Year
- OGEN N/A
- IPDN 2013
- Fundamental
- Price
- OGEN $1.24
- IPDN $2.93
- Analyst Decision
- OGEN
- IPDN
- Analyst Count
- OGEN 0
- IPDN 0
- Target Price
- OGEN N/A
- IPDN N/A
- AVG Volume (30 Days)
- OGEN 99.5K
- IPDN 17.3M
- Earning Date
- OGEN 11-12-2025
- IPDN 11-13-2025
- Dividend Yield
- OGEN N/A
- IPDN N/A
- EPS Growth
- OGEN N/A
- IPDN N/A
- EPS
- OGEN N/A
- IPDN N/A
- Revenue
- OGEN N/A
- IPDN $6,459,379.00
- Revenue This Year
- OGEN N/A
- IPDN N/A
- Revenue Next Year
- OGEN N/A
- IPDN N/A
- P/E Ratio
- OGEN N/A
- IPDN N/A
- Revenue Growth
- OGEN N/A
- IPDN N/A
- 52 Week Low
- OGEN $1.01
- IPDN $0.97
- 52 Week High
- OGEN $18.90
- IPDN $12.39
- Technical
- Relative Strength Index (RSI)
- OGEN 51.14
- IPDN 46.31
- Support Level
- OGEN $1.10
- IPDN $2.53
- Resistance Level
- OGEN $1.18
- IPDN $12.39
- Average True Range (ATR)
- OGEN 0.05
- IPDN 1.78
- MACD
- OGEN 0.05
- IPDN -0.27
- Stochastic Oscillator
- OGEN 93.75
- IPDN 9.90
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.